CAS 304909-07-7: N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenyl-pyrazol-4-yl)methanimine

SANT-1 is a potential biomarker that belongs to the class of small molecules. It is structurally similar to ATP and can bind to bacterial 16S ribosomal RNA, inhibiting transcriptional regulation. The compound has been shown to act as an inhibitor of mitochondrial membrane potential and may be used in skin cancer treatment. SANT-1 has also been shown to inhibit human pathogens such as Streptococcus pyogenes, Staphylococcus aureus, Pseudomonas aeruginosa, and Mycobacterium tuberculosis.

SANT-1

Applications A potent antagonist of the sonic hedgehog (Shh) signaling pathway (IC50=20nm inShh-LIGHT2 assay an d in Ptch1-/- cells) that acts by binding to smoothened (Smo: KD=1.2 nM), a distant relative of G protein-coupled receptors. In contrast to cyclopamine, SNAT-1 inhibits the activities of both wild type and oncogenic Smo with equal potency (IC50=30nm in SmoA1-LIGHT2 assay). References Chen, J.K., et al.: Proc. Natl. Acad. Sci. USA, 99, 14071 (2002), Frank-Kamenetsky, M., et al.: J. Biol. 1, 10 (2002)

SANT-1

SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).